Aneurysm Repair Timing After aSAH: Critical Factors That Drive Outcomes
A comprehensive systematic review spanning 20 studies and over 11,000 patient records has found that while earlier aneurysm repair after aneurysmal subarachnoid hemorrhage (aSAH) is associated with reduced rebleeding before treatment, there is no consistent evidence that the timing of surgery independently improves survival or functional recovery. The findings, published in the Journal of Neurology, raise important questions about how clinicians should approach the urgency of aneurysm securement.
Researchers examined outcomes across treatment windows ranging from less than six hours to more than 15 days after symptom onset. The clearest benefit of early intervention appeared in the reduction of pretreatment rebleeding, particularly in analyses that included patients who received no treatment or whose care was significantly delayed. However, among patients who all received treatment, results were inconsistent. This was largely due to survivor bias and confounding by indication, meaning that critically ill patients were often rushed into surgery while those with milder conditions could wait, skewing comparisons.
When it came to mortality, the evidence was far less decisive. Twelve studies provided timing-based mortality analyses, but their conclusions diverged: two favored earlier treatment, three favored later treatment, four found no meaningful difference, and three reported trends that did not reach statistical significance. Two large observational studies treated timing as a continuous variable and identified U-shaped curves suggesting an optimal window, with one pointing to roughly 32.6 hours after onset and another near 12.2 hours. The authors were quick to caution that these patterns are highly vulnerable to bias and should not be read as justification for delaying surgery.
Similarly, no reproducible link emerged between treatment timing and functional outcomes. More rigorous, adjusted analyses generally failed to show a clear independent effect. The review also assessed vasospasm, delayed cerebral ischemia, hydrocephalus, and hospital length of stay, finding no consistent relationship with when the aneurysm was repaired.
The authors rated the certainty of mortality evidence as very low, citing serious risk of bias, inconsistency, and imprecision. They noted that while the observed patterns could inspire future research, they do not establish an optimal therapeutic window. Crucially, the review reaffirmed that current clinical guidance recommending aneurysm repair as early as feasible remains appropriate. The researchers called for prospective, multicenter studies employing continuous time modeling and stronger methods to address confounding and survivor bias before any changes to standard practice are entertained.
Reference: Fiore TFO et al. Timing of aneurysm repair and clinical outcomes after aneurysmal subarachnoid hemorrhage: a systematic review. J Neurol. 2026; DOI:10.1007/s00415-026-14063-x.
Original Source: https://www.emjreviews.com/neurology/news/aneurysm-treatment-timing-fails-to-show-clear-benefit/
Category:
Tags:
Publish Date: 2026-09-19 16:35:00